Skip to main content

Table 3 Disease-free survival and overall survival (in months) of uterine sarcoma patients stratified on the histological type (n = 40)

From: Prognostic factors, oncological treatment and outcomes of uterine sarcoma: 10 years’ clinical experience from a tertiary care center in Pakistan

Characteristics

All patients (n)

u-LMS

HGESS

LGESS

Other histologic subtypes

p-value*

Disease-free survival (Median, IQR)

12 (3–30)

12 (4–32)

12 (2–37)

8 (3–23)

9.5 (3–22)

 < 0.001

Overall survival (Median, IQR)

14 (3–76)

37 (4–57.5)

19 (2–46)

13.5 (7–27)

14 (3–23)

 < 0.001

  1. *Log-rank test